Hripsime Artjun BOHCHELIAN, Anelia Dimitrova KLISAROVA, Lidia Asenova KOEVA

Radioimmune imaging of diabetic foot infection Tc-99m-labelled antigranulocyte antibody in combination with Tc-99m-methylene diphosphonate bone scintigraphy

The aim of this study was to evaluate the clinical efficacy of immunoscintigraphy with Tc-99m-labelled antigranulocyte antibody in combination with Tc-99m-methylene-diphosphonate (MDP) bone scanning in diabetic foot infection. The study group comprised 42 Type 2 diabetics with foot infection. Pre- and postprandial blood glucose level, HbA1c, urinary glucose, microalbuminuria, total cholesterol, LDL-cholesterol, HDL-cholesterol, and bacteriological cultures were analyzed. Investigation of transcutaneous oxygen tension, vibration sensation, electromyo-graphy, and Doppler ankle/brachial systolic blood pressure index was carried out. Radiographs centered on the feet were performed. All patients underwent bone scintigraphy with 370 MBq Tc-99m-MDP three hours after injection in 3 projections. Radioimmune planar imunoscintigraphy was performed with 740 MBq Technetium - 99m conjugated with monoclonal antigranulocyte antibody BW 250/183 in the same three projections. Immunoscintigraphy was performed 4 and 24 hours after administration of 740 MBq Tc-99m-MAB BW 250/183 in positive bone scan cases. Final assessment of immunoscintigraphic images based on parallel analysis of isotopic images and final diagnosis revealed 21 true positive cases, 16 true negative cases, 3 false positive cases, and 2 false negative cases. The analysis of diagnostic validity revealed a diagnostic accuracy of 86 %. Immunoscintigraphy with Tc-99m-labelled antigranulocyte antibody in combination with Tc-99m-MDP bone scanning is an efficient method for the early detection of foot bone infection and the precise diagnosis of osteomyelities in diabetics.

PDF

___

1. Armstrong DG, Lavery LA. Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician 57: 1325- 32, 1998.
2. Currie CJ, Morgan CL, Peters JR. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. Diabetes Care 21: 42-8,1998.
3. Mancini L, Ruotolo V. The diabetic foot: epidemiology. Rays 22: 511-23, 1997.
4. Slovenkai MP. Foot problems in diabetes. Med Clin North Am 82: 949-71, 1998.
5. Vowden K. Diabetic foot complications. J Wound Care 6: 4-8, 1997.
6. Mayfield JA, Reiber GE, Nelson RG, Greene T. Do foot examinations reduce the risk of diabetic amputation? J Fam Pract 49 - Suppl: 499-504, 2000.
7. Smith RJ. Saving the diabetic foot. J Natl Med Assoc 92: 405-10, 2000.
8. Frykberg RG, Armstrong DG, Giurini J, Edwards A, Kravette M, Kravitz S, Ross C, Stavosky J, Stuck R, Vanore J. Diabetic foot disorders. A clinical practice guideline for the American College of Foot and Ankle Surgeons and the American College of Foot and Ankle Orthopedics and Medicine. J Foot Ankle Surg suppl: 1-60, 2000.
9. Becker W, Goldenberg DM, Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Seminars in nuclear medicine, 14: 142-153, 1994.
10. Dominguez-Gadea L, Martin-Curto LM, de la Calle H, Crespo A. Diabetic foot infections: scintigraphic evaluation with 99Tcm-labelled anti - granulocyte antibodies. Nuclear Medicine Communications, 14: 212-218, 1993.
11. Fox IM, Zeiger L. Tc-99m-HMPAO leukocyte scintigraphy for the diagnosis of osteomyelitis in diabetic foot infections. J Foot Ankle Surg, 32: 591-594, 1993.
12. Krznaric E, De Roo M, Verbrugen A, Stuyck J, Mortelmans L. Chronic osteomyelitis: diagnosis with technetium -99m-d,l,-hexamethylpropylene amine oxime labelled leucocytes. E J Nucl Med, 23: 792-797, 1996.
13. Newman LG. Imaging techniques in the diabetic foot. Clinics in Podiatric Medicine & Surgery, 12: 75-86, 1995.
14. Oyen WJ, Netten PM, Lemmens JA, Corstens FH. Evaluation of infectious diabetic foot complications with indium- 111-labeled human nonspecific immunoglobulin G. J Nucl Med, 33: 1330-1336, 1992.
15. Wang DC, Kottamassu SR, Karvelis K. Scintigraphy in metabolic bone disease. In: Primer on the metabolic bone diseases and disorders of mineral metabolism. Raven Press Ltd. 1993, 129-136, 1993.
16. Gibbons GW, Habershaw GM. Diabetic foot infections. Anatomy and surgery. Infectious Disease Clinics of North America, 9: 131-142, 1995.
17. Lupo MM. An overview of foot disease associated with diabetes mellitus. Medsurg Nurs 6: 225-9, 1997.
18. Devillers A, Moisan A., Hennion F, Garin E, Poirier GY, Bourguet P. Contribution of Technetium -99m hexamethyl-propylene amine oxime labelled leucocyte scintigraphy to the diagnosis of diabetic foot infection. Eur J Nucl Med, 25: 132-137, 1998.
19. Lind P, Langsteger W, Koltringer P, Dimai HP, Passl R, Eber O. Immunoscintigraphy of inflammatory process with a Technetium - 99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183). J Nucl Med, 31: 417-423, 1990.
20. Scheidler J, Leinsinger G, Pfahler M, Kirsch CM, Diagnosis of osteomyelitis. Accuracy and limitations of antigranulocyte antibody imaging compared to three-phase bone scan. Clin. Nucl. Med, 19: 731-737, 1994.